Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain
Not Applicable
Completed
- Conditions
- Chronic Pain
- Registration Number
- NCT02117921
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Brief Summary
To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Adult patient 18 > years old
- Chronic pain without clear organic etiology after full evaluation by primary care physician or subspecialist
- Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment
Exclusion Criteria
- Patients < 18 years of age
- Diagnosed organic disease as cause of pain, such as but not limited to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis)
- Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia and bi-polar disorder. Mild to moderate depression and anxiety will not be considered as exclusions
- Pregnancy
- Severe depression or recent suicide attempt
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Brief Pain Inventory Questionnaire 4 weeks To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
SF-12 Health Survey Scoring Demonstration 4 weeks
- Secondary Outcome Measures
Name Time Method SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score 2 weeks, 4 weeks, 6 months
Trial Locations
- Locations (1)
Beth Israel Deaconess Medical Center
🇺🇸Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center🇺🇸Boston, Massachusetts, United States